Old antibiotics for infections in critically ill patients
Abstract
The declining investment of the pharmaceutical industry in the development of new antibiotics and the increasing antimicrobial resistance create a fertile ground for the study and, probably, revival of older antibiotics for use, especially in critically ill patients.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Bacterial
drug resistance
anti-bacterial agents / therapeutic use*
critical illness*
drug utilization
gentamicins / therapeutic use
chloramphenicol / therapeutic use
cross infection / drug therapy*
pmid:17762241
doi:10.1097/mcc.0b013e32827851d7
matthew e falagas
petros kopterides
fosfomycin / therapeutic use
fusidic acid / therapeutic use
polymyxins / therapeutic use
Access
Citation
ID:
274211
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
274211
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet